Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -7.52 | 14.34 |
| PEG Ratio (TTM) | 0.02 | 4.45 |
| P/S Ratio (TTM) | 0.25 | 1.49 |
| P/B Ratio (TTM) | 0.44 | 2.67 |
| P/FCF Ratio (TTM) | 3.47 | 12.46 |
| Price to 5YR AVG Earnings Ratio | -0.58 | -2.29 |
| Price to 5YR AVG FCF Ratio | 20.25 | 48.79 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.65% | 8.33% |
| ROE (TTM) | -6.02% | 20.04% |
| Net Profit Margin (TTM) | -3.35% | 11.00% |
| ROIC 5YR AVG | -8.23% | 6.11% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.65% | 16.32% | -46.25% |
| Revenue | 2.67% | -16.99% | -3.21% |
| Net Income | -4.10% | 15.32% | -91.61% |
| Cash Flow | 189.69% | 1,207.84% | 752.26% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.69 | 1.82 |
| Quick Ratio (TTM) | 1.19 | 1.31 |
| D/E Ratio (TTM) | 0.57 | 0.76 |
| Interest Coverage (TTM) | 1.09 | 12.05 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 0.43 | 2.87 |
| LTL to 5YR AVG FCF | 13.37 | 9.77 |
| Shares Outstanding Growth 5YR AVG | 16.65% | 7.00% |